title: Correspondence re: Feyler et al., Point: Myeloperoxidase (-463)G --> a polymorphism and lung cancer risk. Cancer Epidemiol. Biomark. Prev., 11: 1550-1554, 2002, and Xu et al., Counterpoint: The myeloperoxidase (-463)G --> a polymorphism does not decrease lung cancer susceptibility in Caucasians. 11: 1555-1559, 2002.
authors.forename: Heike
authors.initials: H
authors.lastname: Dally
authors.forename: Helmut
authors.initials: H
authors.lastname: Bartsch
authors.forename: Angela
authors.initials: A
authors.lastname: Risch
mesh_terms: D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D008175:Lung Neoplasms / Q000453:epidemiology / Q000235:genetics*; D008297:Male; D009195:Peroxidase / Q000235:genetics*; D017354:Point Mutation; D011110:Polymorphism, Genetic; D044465:White People / Q000235:genetics*
chemical_list: D009195:Peroxidase